BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

PAREXEL International (Durham, North Carolina) 

1000 Park Forty Plaza
Suite 400-500
Durham  North Carolina  27713  U.S.A.
Phone: 919-544-3170 Fax: 919-544-3410


SEARCH JOBS


PAREXEL International is one of the largest bio/pharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the global pharmaceutical, biotechnology and medical device industries.

With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed a deep base of knowledge across the entire range of the drug development continuum, and shares its significant expertise with clients, employing a customizable and collaborative approach.

PRODUCTS AND SERVICES

PAREXEL Consulting's scientific, regulatory and business professionals offer clients expert guidance in all phases of the worldwide drug development and medical device lifecycles. Its unique ability to design strategies and execute solutions help clients to bring new products to market fast and assist clients in reducing time to peak sales.

PAREXEL Medical Marketing Services provides integrated strategic product commercialization services to international, U.K., and U.S. pharmaceutical companies. In addition to its innovative creative services unit, its health policy and strategic reimbursement expertise, and its educational seminars, PAREXEL Medical Marketing also offers advanced patient recruitment and retention capabilities, including real-time data processing, global access, and on-going site monitoring.

PAREXEL Clinical Research offers Phase I - IV strategy development, clinical trials management, biostatistics and data management, medical writing, pharmacovigilance, and site management services.

Perceptive Informatics, Inc., the information technology subsidiary of PAREXEL International, develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development. Its technology portfolio includes web-based portal solutions and tracking tools, Interactive Voice Response Systems (IVRS), Clinical Trial Management Systems (CTMS), electronic diary and investigator database solutions.

Headquartered near Boston, MA, PAREXEL International operates in 52 locations throughout 35 countries around the world, and has more than 4,800 employees.

www.parexel.com

Last Updated: 11-29-04


 Key Statistics


Email:
Ownership: Public

Web Site: PAREXEL International (Durham, North Carolina)
Employees:
Symbol: PRXL
 



Industry
Services






 Company News
PAREXEL International (PRXL) Provides Update On Expected Third Quarter Fiscal 2005 Financial Results 10/19/2005 5:13:04 PM    More...
PAREXEL Consulting To Validate First cGMP Biopharmaceutical Contract Manufacturing Facility In South Korea 10/19/2005 5:12:15 PM    More...
PAREXEL International (PRXL) Acquires QdotPharma, a Phase I/IIa Clinical Pharmacology Unit 10/19/2005 5:11:57 PM    More...
PAREXEL International (PRXL) Reports First Quarter Fiscal 2005 Financial Results 10/19/2005 5:11:52 PM    More...
PAREXEL International (PRXL) Reports Third Quarter Fiscal 2005 Financial Results 10/19/2005 5:11:02 PM    More...
PAREXEL International (PRXL) Acquires Clinical Pharmacology Units 3ClinicalResearch (PRXL); $12 Million 10/19/2005 5:10:59 PM    More...
PAREXEL International (PRXL) Appoints Professor Herman Scholtz As Vice President And Worldwide Head Of Clinical Pharmacology 10/19/2005 5:10:02 PM    More...
PAREXEL International (PRXL): New Text First To Profile U.S. Biologics Product Regulation Following CBER/CDER Consolidation 10/19/2005 5:09:55 PM    More...
PAREXEL International (PRXL) To Present At UBS Warburg Global Healthcare Services Conference 10/19/2005 5:09:47 PM    More...
PAREXEL International (PRXL) Announces Fourth Quarter Restructuring Charge; Relocation Or Elimination Of Approximately 150 Positions 10/19/2005 5:09:43 PM    More...
12